Maria-Angeles Foncillas

9PUBLICATIONS
85CO-AUTHORS
Haematological tumoursNanomedicineCardiovascular medicine and haematology not elsewhere classifiedRespiratory diseasesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 04, 2026
Temporal Trends in Real-World Outcomes With CPX-351 in Secondary/High-Risk Acute Myeloid Leukemia: A PETHEMA Study.

|Oct 06, 2026
Venetoclax-based therapy versus hypomethylating agents alone in unfit patients with newly diagnosed acute myeloid leukemia: a real-world study from the PETHEMA registry.

|Oct 17, 2025
Coexisting Myeloproliferative and Lymphoid Neoplasms: A European Multicenter Retrospective Study.

Dolly Viviana Fiallo-Suárez, Ruth Stuckey, Cristina Bilbao-Sieyro

|May 14, 2022
Azacitidine vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the PETHEMA Registry.

Jorge Labrador, David Martínez-Cuadrón, Adolfo de la Fuente

|Apr 12, 2022
Use of Venetoclax in Patients with Relapsed or Refractory Acute Myeloid Leukemia: The PETHEMA Registry Experience.

Jorge Labrador, Miriam Saiz-Rodríguez, Dunia de Miguel

|Feb 10, 2021
Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19.

Tiziano Barbui, Valerio De Stefano, Alberto Alvarez-Larran

Pageof 2

Frequent Collaborators

5 joint publications

Elisa Rumi

5 joint publications

Gonzalo Carreno-Tarragona

5 joint publications

Juan Carlos Hernandez-Boluda

4 joint publications

Tiziano Barbui